Toronto, ON

Wednesday November 16th  &
Thursday November 17th 2016

  • Save the date November 16-17 2016. Request Updates.

Thank you for attending Market Access Canada!

Hundreds of attendees came together at the 14th Annual Market Access Summit to discuss, debate and demonstrate their industry expertise. Leading experts from the industry like AstraZeneca, Teva, Alcone and Janssen joined key regulators like PMPRB, CADTH and the pCPA. Some of the key topics of discussion were:

  • Smart spending vs. dumb spending on treatment
  • Implications of the rising cost of specialty drugs
  • Considering the patient voice and experience
  • Confidentiality in negotiations
  • Interest-based, collaborative approached with market actors

These discussions have helped to improve access to medicines yet again. Thank you for being a part of it. We look forward to seeing you in 2016 when we will continue the conversation with the latest developments in this fast-moving field.

Be A Speaker Be A Sponsor

Here’s what some of the attendees were saying at this year’s event

“Good update of new developments”
Cheryl Cann, Boehringer Ingelheim

“Great Day 1 program!”
Maya Daher, Janssen Inc

2015 Speakers

Ashley Metz
Director of Pharmaceutical Policy & Appropriateness
Saskatchewan Ministry of Health
View bio
Douglas Clark
Executive Director
Patented Medicine Prices Review Board
View bio
Laureen Rance
Director, Pharmaceutical Relations
Manulife Financial
View bio
Jane Farnham
Former Chair
Canadian Pharmacists Association
View bio
Peter Gove
Innovation Leader – Health Management
GreenShield Canada
View bio
Beth Molloy-Whaley
Senior Director Strategic Consulting
Innomar Strategies
View bio
Colin Vicente
Managing Director
View bio
Brent Fraser
VP of Pharmaceutical Reviews
View bio
View all speakers

Event takes place in...

0 0 0
0 0
0 0
0 0

Download Preview Agenda

  • This field is for validation purposes and should be left unchanged.